These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1271 related articles for article (PubMed ID: 15943410)

  • 1. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations in molecular detection of lymph node micrometastasis from colorectal cancer.
    Klebig F; Fischer C; Petri S; Gerull H; Wagener C; Tschentscher P
    Diagn Mol Pathol; 2007 Jun; 16(2):91-5. PubMed ID: 17525678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients.
    Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T
    Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer.
    Lauschke H; Caspari R; Friedl W; Schwarz B; Mathiak M; Propping P; Hirner A
    Cancer Detect Prev; 2001; 25(1):55-61. PubMed ID: 11270422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers.
    Wang JY; Hsieh JS; Chang MY; Huang TJ; Chen FM; Cheng TL; Alexandersen K; Huang YS; Tzou WS; Lin SR
    World J Surg; 2004 Jul; 28(7):721-6. PubMed ID: 15185002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of fecal and blood adenomatous polyposis coli gene and K-ras gene mutation detection in colorectal neoplasm screening].
    Zhan J; Li X; Yu Z; Yuan YH; Hou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1018-21. PubMed ID: 17666342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
    Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.
    Smith G; Carey FA; Beattie J; Wilkie MJ; Lightfoot TJ; Coxhead J; Garner RC; Steele RJ; Wolf CR
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9433-8. PubMed ID: 12093899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
    Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
    Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.
    Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M
    Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
    Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
    Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
    Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
    Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
    J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence.
    Kato M; Ito Y; Kobayashi S; Isono K
    Cancer; 1996 Apr; 77(8 Suppl):1729-35. PubMed ID: 8608570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
    Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
    Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.